Relationship between mRNA Levels Quantified by Reverse Transcription-Competitive PCR and Metabolic Activity of CYP3A4 and CYP2E1 in Human Liver

This publication has 9 references indexed in Scilit:

• Interindividual Differences in Hepatic Expression of CYP3A4: Relationship to Genetic Polymorphism in the 5′-Upstream Regulatory Region
  Biochemical and Biophysical Research Communications, 1999
• Evaluation of Induction of CYP3A mRNA Using the HepG2 Cell Line and Reverse Transcription-PCR.
  Biological & Pharmaceutical Bulletin, 1999
• Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype
  Pharmacogenetics, 1998
• Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
  JNCI Journal of the National Cancer Institute, 1998
• Quantification of Multiple Human Cytochrome P450 mRNA Molecules Using Competitive Reverse Transcriptase-PCR
  DNA and Cell Biology, 1998
• HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes
  Toxicology Letters, 1997
• Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions
  Clinical Pharmacokinetics, 1997
• Characterization of mRNA Species Related to Human Liver Cytochrome P-450 Nifedipine Oxidase and the Regulation of Catalytic Activity
  Journal of Biological Chemistry, 1989
• Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450.
  Journal of Biological Chemistry, 1984